temafloxacin has been researched along with erythromycin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 10 (76.92) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Fenoll, A; López de Felipe, F; Martínez-Suárez, JV; Rodríguez-Tudela, JL | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
| Gikas, A; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
| Allen, W; Gorzynski, EA; Gutman, SI | 1 |
| Eliopoulos, GM; Ferraro, MJ; Malanoski, GJ; Moellering, RC | 1 |
| Ikerd, TR; Koletar, SL | 1 |
13 other study(ies) available for temafloxacin and erythromycin
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
Studies show new macrolide antibiotics to be superior to some older agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Quinolones | 1992 |
Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cerebrospinal Fluid; Daptomycin; Erythromycin; Fluoroquinolones; Glycopeptides; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Quinolones; Serotyping; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins | 1991 |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Azithromycin; Cell Division; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Leprostatic Agents; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 1991 |
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones | 1991 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Enoxacin; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Pefloxacin; Quinolones | 1989 |
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolones | 1993 |
In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Fluoroquinolones; Giardia lamblia; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1993 |